Breast cancer—The catalyst of contemporary trials design

Zahraa Al-Hilli; Anna Weiss; Ava Armani; Judy C. Boughey; Sarah L. Blair

doi:10.1002/jso.26722

Breast cancer—The catalyst of contemporary trials design

Zahraa Al-Hilli, Anna Weiss, Ava Armani, Judy C. Boughey, Sarah L. Blair

Gastroenterologic and General Surgery

Research output: Contribution to journal › Review article › peer-review

Abstract

Surgical trials in breast cancer have catalyzed contemporary trial design for solid organ cancers and are a prime example of surgeons taking the lead in clinical trial design. Surgeons have lead trials that have improved patient outcomes and quality of life without sacrificing oncologic safety. We have evolved from radical mastectomy to breast conservation and sentinel node biopsy. Contemporary trial design in breast cancer now focus on personalizing care based on tumor genomics.

Original language	English (US)
Pages (from-to)	7-16
Number of pages	10
Journal	Journal of Surgical Oncology
Volume	125
Issue number	1
DOIs	https://doi.org/10.1002/jso.26722
State	Published - Jan 2022

Keywords

breast conservation trials
breast surgery clinical trials
breast surgery de-escalation

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1002/jso.26722

Cite this

@article{24ed696d6a954955af16b4358aca9225,

title = "Breast cancer—The catalyst of contemporary trials design",

abstract = "Surgical trials in breast cancer have catalyzed contemporary trial design for solid organ cancers and are a prime example of surgeons taking the lead in clinical trial design. Surgeons have lead trials that have improved patient outcomes and quality of life without sacrificing oncologic safety. We have evolved from radical mastectomy to breast conservation and sentinel node biopsy. Contemporary trial design in breast cancer now focus on personalizing care based on tumor genomics.",

keywords = "breast conservation trials, breast surgery clinical trials, breast surgery de-escalation",

author = "Zahraa Al-Hilli and Anna Weiss and Ava Armani and Boughey, {Judy C.} and Blair, {Sarah L.}",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC",

year = "2022",

month = jan,

doi = "10.1002/jso.26722",

language = "English (US)",

volume = "125",

pages = "7--16",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "1",

}

TY - JOUR

T1 - Breast cancer—The catalyst of contemporary trials design

AU - Al-Hilli, Zahraa

AU - Weiss, Anna

AU - Armani, Ava

AU - Boughey, Judy C.

AU - Blair, Sarah L.

PY - 2022/1

Y1 - 2022/1

N2 - Surgical trials in breast cancer have catalyzed contemporary trial design for solid organ cancers and are a prime example of surgeons taking the lead in clinical trial design. Surgeons have lead trials that have improved patient outcomes and quality of life without sacrificing oncologic safety. We have evolved from radical mastectomy to breast conservation and sentinel node biopsy. Contemporary trial design in breast cancer now focus on personalizing care based on tumor genomics.

AB - Surgical trials in breast cancer have catalyzed contemporary trial design for solid organ cancers and are a prime example of surgeons taking the lead in clinical trial design. Surgeons have lead trials that have improved patient outcomes and quality of life without sacrificing oncologic safety. We have evolved from radical mastectomy to breast conservation and sentinel node biopsy. Contemporary trial design in breast cancer now focus on personalizing care based on tumor genomics.

KW - breast conservation trials

KW - breast surgery clinical trials

KW - breast surgery de-escalation

UR - http://www.scopus.com/inward/record.url?scp=85120960128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120960128&partnerID=8YFLogxK

U2 - 10.1002/jso.26722

DO - 10.1002/jso.26722

M3 - Review article

C2 - 34897706

AN - SCOPUS:85120960128

SN - 0022-4790

VL - 125

SP - 7

EP - 16

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

IS - 1

ER -

Breast cancer—The catalyst of contemporary trials design

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this